Becton, Dickinson and Company BDX, more commonly known as BD, introduced BD FACSCelesta flow cytometer at the recent 2015 American Society for Cell Biology annual meeting. The solution is primarily ...

Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry in Oncology and Immunology Market - A Global Market and Regional: Focus on Offering, Technology, End User, Type, Application, and Country ...

FRANKLIN LAKES, N.J. & SAN DIEGO--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory automation ...

Delray Beach, FL, June 13, 2025 (GLOBE NEWSWIRE) -- Ever wondered how scientists peek inside our cells, analyzing their secrets to diagnose diseases or develop life-saving therapies? It's all thanks ...

The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...

In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. announced the launch of the Cytek Aurora Evo system, a new full spectrum flow cytometer that ...

Champions Oncology (CSBR) announced advancements in its bioanalytical services portfolio, specifically, expanding its capabilities with the integration of multiple global Cytek Aurora flow cytometers ...

Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry market is projected to reach $2.04 billion by 2035 from $928.3 million in 2024, ...

Cytek Biosciences, Inc. has announced the launch of the Cytek Aurora™ Evo system, an advanced full spectrum flow cytometer designed to enhance cell analysis capabilities. Building on the success of ...

BD (Becton, Dickinson and Company), a leading global medical technology company, and Biosero, a developer of laboratory automation solutions to orchestrate scientific discoveries, announced a ...

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory ...